TP53 and cancer: MDM2 is a known inhibitor of p53, but MDM2 also has over one-hundred other interacting proteins whose link to p53 inhibition and cell growth controls are not well defined; nor is there an annotation of which of these over hundred MDM2 interactors are dominant or less significant which would clarify their importance as therapeutic targets in cancer [27].